Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
3
×
boston blog main
boston top stories
gene editing
life sciences
national blog main
san francisco blog main
3
×
biotech
crispr
deals
editas medicine
feng zhang
national top stories
san francisco top stories
abbvie
agios therapeutics
allergan
alzheimer's disease
base editing
branden moriarty
broad institute
cas13
clinical trials
crispr therapeutics
crispr-cas9
cynthia collins
david liu
david walt
diagnostics
dna
editor
editr
enzyme
harvard university
illumina
intellia therapeutics
jennifer doudna
jim collins
john evans
keith joung
What
editing
3
×
gene
3
×
crispr
editas
medicines
abbvie
alliance
beam
bio
biotech
cas
create
diagnostic
diseases
editor
exits
experimental
fix
founders
genetic
gotten
harvard
heats
high
human
jump
launches
mass
medicine
pact
partnership
precise
pruning
race
research
returning
rights
scientists
sherlock
spotlights
Language
unset
Current search:
gene
×
boston
×
editing
×
" san francisco blog main "
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M
@xconomy.com
5 years ago
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M